n,n-dimethylarginine has been researched along with Diabetic Neuropathies in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, W; He, K; Li, C; Liu, J; Ma, B; Ma, H; Tian, L; Zhao, P | 1 |
| Kendirli, T; Önem, Y; Özdağ, F; Saraçoğlu, M; Senol, MG; Yaşar, H | 1 |
| El-Mesallamy, HO; Ezzat, OA; Hamdy, NM; Reda, AM | 1 |
1 review(s) available for n,n-dimethylarginine and Diabetic Neuropathies
| Article | Year |
|---|---|
Relationship between Serum Asymmetric Dimethylarginine Level and Microvascular Complications in Diabetes Mellitus: A Meta-Analysis.
Topics: Arginine; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Neuropathies; Diabetic Retinopathy; Female; Humans; Male; Risk Factors | 2019 |
2 other study(ies) available for n,n-dimethylarginine and Diabetic Neuropathies
| Article | Year |
|---|---|
Serum asymmetric dimethylarginine levels in diabetic patients with neuropathy.
Topics: Adult; Aged; Aged, 80 and over; Arginine; Diabetic Neuropathies; Electrophysiology; Female; Humans; Male; Middle Aged | 2011 |
Levels of soluble advanced glycation end product-receptors and other soluble serum markers as indicators of diabetic neuropathy in the foot.
Topics: Aged; Arginine; Biomarkers; Diabetes Mellitus, Type 2; Diabetic Foot; Diabetic Neuropathies; Glycated Hemoglobin; Humans; Male; Middle Aged; Nitric Oxide; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Solubility | 2011 |